As shown in Figure 3A (upper panel), although treatment of the tumor-bearing mice solely with murine anti-CD19 CAR T cells suppressed tumor growth, cotreatment with the same CAR T cells plus FA-TLR7-1A improved this therapeutic potency. Here, CD19 is linked to neoplasm.